Alison M. Weppler
- Co-authors
- Shahneen SandhuGeorgina V. LongGeorge Au‐YeungMatteo S. CarlinoRodney J. HicksAmir IravaniAlexander M. MenziesRoslyn Wallace
- Topics
- Cancer Immunotherapy and Biomarkers (16 papers)CAR-T cell therapy research (6 papers)Melanoma and MAPK Pathways (6 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaRadiology
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Alison M. Weppler
22 papers receiving 291 citations
Peers
Comparison fields: 5 of 40
- Oncology 233
- Pulmonary and Respiratory Medicine 63
- Molecular Biology 62
- Immunology 62
- Cancer Research 58
Countries citing papers authored by Alison M. Weppler
This map shows the geographic impact of Alison M. Weppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Weppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Weppler more than expected).
Fields of papers citing papers by Alison M. Weppler
This network shows the impact of papers produced by Alison M. Weppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Weppler. The network helps show where Alison M. Weppler may publish in the future.
Co-authorship network of co-authors of Alison M. Weppler
This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Weppler. A scholar is included among the top collaborators of Alison M. Weppler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Weppler. Alison M. Weppler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 14 | |
| 4 | 11 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 19 | |
| 8 | 0 | |
| 9 | 0 | |
| 10 | 45 | |
| 11 | 62 | |
| 12 | 8 | |
| 13 | 1 | |
| 14 | 49 | |
| 15 | 3 | |
| 16 | 10 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 35 | |
| 20 | Response assessment and immune-related adverse events as detected by FDG PET/CT in patients treated with combined CTLA-4 and PD-1 checkpoint inhibitors as first-line therapy in advanced melanoma | 2 |
About Alison M. Weppler
Alison M. Weppler is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 294 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (6 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Oncology (233 citations), Cancer Research (58 citations) and Immunology (62 citations). Alison M. Weppler has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Shahneen Sandhu, Georgina V. Long, George Au‐Yeung, Matteo S. Carlino, Rodney J. Hicks, Amir Iravani, Alexander M. Menzies, Roslyn Wallace, Célèste Lebbé and Peter K. H. Lau. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.